GrantExec

Grants for Independent school districts - Federal

Explore 2,482 grant opportunities

Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
$500,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 19, 2024

Date Added

Nov 6, 2023

This funding opportunity supports innovative research projects that explore the effective use and sharing of genomic information in clinical care for diverse populations, regardless of their racial, ethnic, or socioeconomic backgrounds.

Health
State governments
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 4, 2024

Date Added

Mar 21, 2024

This funding opportunity supports researchers in developing and testing innovative devices for diagnosing and treating disorders of the nervous system through small clinical studies and safety assessments.

Education
State governments
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
$275,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 30, 2024

Date Added

Nov 21, 2022

This grant provides funding for researchers to explore how diet and lipid metabolism influence tumor growth and progression, encouraging innovative studies that connect nutrition science with cancer biology.

Education
State governments
NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
$50,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 7, 2025

Date Added

Dec 5, 2022

This grant provides funding for small-scale cancer research projects that can be completed in two years, aimed at supporting innovative studies and methodologies in various areas of cancer research.

Education
State governments
Advancing Strategies to Deliver and Sustain Evidence-Based Chronic Disease Self-Management Education Programs to Support Older Adults with Behavioral Health Conditions
$1,250,000
U.S. Department of Health & Human Services (Administration for Community Living)
Federal

Application Deadline

Aug 15, 2025

Date Added

Jul 29, 2025

This funding opportunity provides financial support to community-based organizations that develop and implement programs to help older adults with behavioral health conditions manage chronic diseases effectively.

Health
State governments
Strengthening and modernizing sustainable public health systems and workforce in Uganda for data science, informatics, surveys, and surveillance for timely, accurate, and integrated data for action under PEPFAR
$20,000,000
U.S. Department of Health & Human Services (Centers for Disease Control-GHC)
Federal

Application Deadline

Feb 18, 2025

Date Added

Jul 26, 2024

This funding opportunity provides financial support to organizations working in Uganda to improve public health data systems and workforce capabilities, focusing on data science and surveillance to enhance health outcomes related to HIV and tuberculosis.

Health
State governments
Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 24, 2025

Date Added

Nov 30, 2023

This funding opportunity supports researchers working to identify and address health and healthcare disparities affecting sexual and gender minority populations, particularly those from racial/ethnic minority and lower socioeconomic backgrounds.

Education
State governments
National Climate Adaptation Science Center Program (NCASC)
$24,050,000
U.S. Department of the Interior (Geological Survey)
Federal

Application Deadline

Feb 3, 2025

Date Added

Sep 30, 2024

This funding opportunity provides financial support to academic institutions, nonprofits, and state and local governments to establish Climate Adaptation Science Centers that will research and develop strategies to help manage the impacts of climate change on natural resources in specific U.S. regions.

Environment
State governments
Notice of Intent to Publish a Funding Opportunity Announcement for NINR Areas of Emphasis for Research to Optimize Health for All (R21 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 16, 2025

Date Added

Nov 26, 2024

This funding opportunity supports innovative research projects aimed at improving health equity and outcomes for diverse and underserved populations, inviting a wide range of organizations to collaborate on addressing critical health challenges.

Health
State governments
NIA Program Project Applications (P01 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Sep 25, 2025

Date Added

May 22, 2025

This funding opportunity supports collaborative research projects focused on aging and age-related diseases, aimed at institutions and organizations dedicated to improving the health and well-being of older adults.

Health
State governments
Graduate Psychology Education Program (GPE)
$450,000
U.S. Department of Health & Human Services (Health Resources and Services Administration)
Federal

Application Deadline

Jan 21, 2025

Date Added

Aug 2, 2024

This funding opportunity provides financial support to accredited psychology training programs to develop skilled professionals in behavioral health, particularly in underserved communities, focusing on trauma-informed care and substance use treatment.

Health
State governments
NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)
$400,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jun 10, 2025

Date Added

Dec 10, 2024

This funding opportunity supports the establishment of research centers that focus on translating diabetes prevention and treatment innovations into real-world practices, particularly for underserved populations facing health disparities.

Food and Nutrition
State governments
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Jul 19, 2024

Date Added

Feb 7, 2024

This grant provides funding for a Data Coordinating Center to support multi-site clinical trials focused on natural products, requiring collaboration with a Clinical Coordinating Center and emphasizing diverse perspectives in research.

Health
State governments
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 2, 2025

Date Added

Jan 18, 2023

This funding opportunity provides support for U.S. institutions to create short-term research training programs for health professional and graduate students interested in biomedical, behavioral, or clinical research careers.

Environment
State governments
NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)
$150,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 9, 2025

Date Added

Mar 2, 2022

This grant provides funding to researchers for developing detailed study protocols and procedures for large-scale vision research projects, without generating new data on interventions.

Health
State governments
Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
$1,500,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Sep 13, 2024

Date Added

Sep 17, 2021

The National Center for Advancing Translational Sciences (NCATS) will award Institutional Research Career Development (K12) programs through the Clinical and Translational Science Awards (CTSA).The National Center for Advancing Translational Sciences (NCATS) will award Institutional Research Career Development (K12) programs through the Clinical and Translational Science Awards (CTSA). The purpose of this Funding Opportunity Announcement (FOA) is to encourage institutions to propose creative and innovative institutional research career development programs designed to prepare an outstanding heterogeneous pool of promising later stage postdoctoral fellows and junior faculty scholars in clinical and translational science who have made a commitment to independent research careers (i.e., tenure-track or equivalent faculty positions), and to facilitate their timely transition to more advanced support mechanisms, e.g., K08, K23, R01, R03, etc. Applicants must submit both a UM1 application to PAR-21-293: Clinical and Translational Science Award and a K12 application to this FOA. This Funding Opportunity Announcement (FOA) allows appointment of Scholars (K12) proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary clinical trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development

Health
State governments
NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed)
$200,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

May 25, 2025

Date Added

Mar 3, 2023

This funding opportunity supports the creation of mentoring networks that provide professional development and career guidance for graduate students, postdoctoral scholars, and early-career researchers in mental health, helping them advance towards independent research careers.

Health
State governments
NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
$351,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 21, 2025

Date Added

Feb 12, 2025

This grant provides funding to educational institutions and organizations to develop programs that support individuals from diverse backgrounds in pursuing careers in biomedical and behavioral research through skills development, research experiences, and mentoring.

Health
State governments
NIDDK Central Repository Non-renewable Sample Access (X01 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Jun 26, 2025

Date Added

Jun 29, 2022

This grant provides access to valuable biological samples and data for researchers studying common and serious health conditions, such as diabetes and kidney diseases, to support innovative research and development of new treatments.

Food and Nutrition
State governments
AHRQ Small Research Grant Program (R03)
$100,000
HHS-AHRQ (Agency for Health Care Research and Quality)
Federal

Application Deadline

Jul 8, 2024

Date Added

May 21, 2018

Small research (R03) grants provide flexibility for initiating studies which are generally for preliminary or short-term projects. These grants are non-renewable. Some examples of the types of projects that R03 research supports include: Pilot or feasibility studies Secondary analysis of existing data Small, self-contained research projects Development of research methodology Development of new research technology The AHRQ small grant is a mechanism for supporting discrete, well-defined projects that realistically can be completed within two years (or less) within the budget constraints of the mechanism. Because the research strategy section of the application is limited to 6 pages, an R03 grant application may not contain the same level of detail as that found in an R01 application. Accordingly, appropriate justification for the proposed work can be provided through literature citations, data from other sources, or from investigator-generated data. Preliminary data are not required, particularly in applications proposing pilot or feasibility studies. The Small Research Grant (R03) is an award made by AHRQ to an institution/organization to support a discrete health services research project. The R03 research strategy proposed by the applicant institution/organization must be related to the mission and research interests of AHRQ, which are detailed below. Although the PD/PI is responsible for conducting and supervising the research, the actual applicant is the research institution/organization legally accountable for the performance of the award and the expenditure of funds. AHRQ Mission and Research Areas of Interest: The AHRQ mission is to produce evidence to make health care safer, higher quality, more acยญcessible, equitable and affordable, and to work with HHS and other partners to make sure that the evidence is understood and used. Within this mission, AHRQโ€™s specific priority areas of focus are: Research to improve health care patient safety. Harnessing data and technology to improve health care quality and patient outcomes and to provide a 360-degree view of the patient. Research to increase accessibility and affordability of health care by examining innovative market approaches to care delivery and financing. Research to Improve Health Care Patient Safety Patient safety is defined as the freedom from accidental or preventable injury produced by health care as well as the practices that create a safe environment of care. The ultimate goal of AHRQ-supported Patient Safety research is to improve the safety of health care delivery. Patient safety research initiatives that lead to this goal can be considered in three different stages: Identification of risks, hazards, and patient harm. Design, implementation, dissemination and spread, and evaluation of interventions to improve patient safety. Establishment of strategies to sustain patient safety improvements such as just culture, incident/event reporting, measurement, monitoring, and surveillance. AHRQ's Patient Safety Research Program: (1) identifies specific areas of focus through targeted grant funding announcements (i.e., Program Announcements, Requests for Applications, and Special Emphasis Notices) and (2) encourages investigators to utilize the Agency's general funding announcements to apply this research framework in response to other patient safety threats and opportunities for improvement. The Patient Safety Portfolio will support research projects to create new knowledge by identifying the risks, hazards, and harm encountered by patients as a result of health care. The Portfolio will also support projects that mitigate those risks, hazards, and harm including the design, implementation and evaluation of strategies (patient safety practices) and the adaptation, refinement, and sustainment of those strategies. These initiatives are part of the Agency's overall mission to improve the quality of health care. AHRQ encourages an interdisciplinary, systems science patient safety approach. In addition to health services research, perspectives from organizational theory, human factors, industrial engineering, facilities design, education, and other disciplines can be incorporated in research plans. Projects may address important topics such as: the surveillance, measurement, detection, and reporting of patient safety events; the impact of human performance, work flow, and working conditions on patient safety; the patients' role and contribution to patient safety; health care safety culture, leadership, communication, teamwork, and simulation; prevention and control of healthcare-associated infections (HAIs); diagnostic safety and quality; the safe use of medical devices and medications, including safely prescribing opioids; the role of Patient Safety Organizations; and the challenges inherent in transitions of care in the same setting and between settings and handoffs between health care providers. Research related to the prevention and control of HAIs is an instructive example of AHRQโ€™s Patient Safety research interests. AHRQ supports research whose short-term or long-term aim is to develop improved methods for preventing HAIs and to develop effective implementation strategies for HAI prevention in all health care settings. Accordingly, AHRQโ€™s foci of interest in HAI research are the following broad areas: Determination of the clinical efficacy and effectiveness of preventive interventions, including unintended adverse consequences. Characterization and assessment of relevant epidemiological aspects of HAIs, including but not limited to patient risk factors, clinical presentation, and sources of antibiotic-resistant organisms involved in the development of HAIs. Demonstration, dissemination, and evaluation of strategies and approaches for prevention and reduction of HAIs. Research regarding adoption and implementation (including sustainment, spread, and scale-up) of evidence-based approaches for prevention of HAIs. The HAI research portfolio also encompasses generation of knowledge for combating antibiotic resistant bacteria. AHRQ is interested in studies to promote appropriate antibiotic use, reduce the transmission of resistant bacteria, and prevent HAIs in the first place. The last contributes to antibiotic stewardship by avoiding the need for antibiotic therapy and precludes the possibility of a resistant infection. Clinical investigations that seek to establish the efficacy or effectiveness of preventive interventions, as noted above, typically involve a comparison of the intervention in question to routine care or, less frequently, to a placebo (when the latter is ethical). Such clinical studies are included in the scope of AHRQโ€™s HAI research portfolio. The HAI Portfolio does not fund comparisons of two interventions of known efficacy or effectiveness to determine which is more efficacious or effective. Such studies are comparative effectiveness research, which is more appropriately funded by other funding sources. The Portfolio supports research in all health care settings including the hospital, long-term care, ambulatory care, home health care, pharmacy, and transitions of care between settings. Patient safety research involves many stakeholder groups including patients, families, clinicians, non-clinical health care staff, policymakers, payers, and health care organizations including providers and accreditors, local and State governments, and the Federal Government, Patient Safety Organizations, and many others. Projects in this area may also address patient characteristics that might influence the risk of experiencing a patient safety event, for example, attributes of AHRQ's priority populations that can impact patient safety and address strategies to address barriers to safe care. Harnessing Data and Technology To Improve Health Care Quality and Patient Outcomes and To Provide a 360-Degree View of the Patient AHRQ is interested in research to: advance the methods of evidence synthesis to ensure scientific rigor and unbiased reviews, make evidence-based recommendations on clinical preventive services, conduct research on how health information technology can improve the quality of health care, advance the science of clinical practice improvement, evaluate and support innovative models of practice transformation in primary care and other ambulatory settings, and facilitate communities of learning to promote the implementation of evidence for practice improvement. Further, AHRQ is interested in studying and improving upon the process by which health systems and ambulatory care practices select evidence to implement and how to determine what strategies are used to implement the evidence into everyday practice. The study of implementation strategies and processes is critical because interventions developed in the context of publically funded efficacy and effectiveness trials are rarely scalable without adaptations to specific settings and additional tools and guidance to support uptake and implementation. AHRQ is also interested in research that advances whole-person, 360-degree care especially those with multiple chronic conditions and/or socioeconomic disadvantage. Whole person, 360-degree care is defined as the coordination of health, behavioral health, intellectual/developmental disabilities, and social services in a person-centered manner with the goals of improved health outcomes and more efficient and effective use of resources in the context of peopleโ€™s lives and the communities they live in. Emphasis is on the orientation of the health care team to consider all domains of a personโ€™s life when assessing and addressing needs. The following lists examples of AHRQ research priorities: Improving health care quality outcomes by providing integrated, coordinated whole-person, 360-degree care to optimize individual and population health outcomes: Generation of knowledge about how clinical teams can most effectively elicit and use a patientโ€™s values; preferences; and personal, social, and clinical context to formulate and use plans of care in partnership with patients, caregivers, and families. Preferences, values, and context may be specific to the situation and also can change over time. Therefore, proposals that address how the process of care planning and the care plans themselves will identify and respond to the specific and dynamic nature of patientsโ€™ circumstances are of interest. Development of information and data to create/foster/support partnerships and linkages between health care and human service systems (community-based organizations and public health) to improve whole-person care. These could be focused on improving care coordination and strengthening care transitions, ensuring that care is fully integrated to support the whole person and family. Improvement of health care quality through the use of information systems and data resources that both provide meaningful clinical decision support to health care professionals and patients and families at the point of care and that capture important actions and outcomes of health care to increase evidence on effective practices and support clinical and organizational improvement. Implementation of clinical prevention guidelines into learning health systems with innovative ways to include patientsโ€™ preferences and values in order to empower whole person-centered care. Development and study of models of shared decision making that are tailored to the needs of disadvantaged populations. Development of whole-person care research to improve health and health services efforts in persons with multiple chronic conditions. Development, implementation, and evaluation of models of primary care for individuals with complexity, including multiple chronic conditions, disability, and socioeconomic disadvantage that improve individual and population health while reducing disparities. Implement research findings in order to accelerate the spread of evidence-based practices by: Implementation of evidence-based approaches to identify, understand, and overcome barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, tools, policies, and guidelines. Research on de-implementation of the use of health system procedures and clinical practices that are ineffective, have been prematurely widely adopted, or are harmful or wasteful. Development of a parsimonious set of meaningful measures to evaluate implementation and impact of whole-person care. Development of innovative ways to use data and health information technology (IT) in primary care practices in order to increase uptake and implementation of preventive services, especially those involving behavioral change (e.g. obesity prevention, substance use prevention). Development of methods underlying the fields of evidence synthesis, stakeholder and patient engagement, decision making, and practice improvement. Accelerating the ability of health care organizations to evolve as learning health systems that effectively apply data and evidence to improve patient outcomes by: Synthesizing, translating, and communicating complex scientific evidence to facilitate informed care planning and health care decision making by patients, families, and health care professionals at the individual level and informed policy decision making at the health system and population level. Discovering, testing, and spreading methods and strategies for health care practice improvement to improve health care quality, including accelerating the sustainable implementation of evidence-based practice. AHRQ has particular interest in practice improvement in primary care and ambulatory settings. Demonstrating the effectiveness of synthesizing, translating, and communicating complex scientific evidence to facilitate informed care planning and health care decision making by patients, families, and health care professionals at the individual level and informed policy decision making at the health system and population level. Research to Increase Accessibility and Affordability of Health Care by Examining Innovative Market Approaches to Care Delivery and Financing Producing evidence that can be used to increase the affordability and efficiency of health care for all Americans is a major AHRQ priority. Potential research areas and questions include but are not limited to the following: Reducing Cost Growth: In order to make health care more affordable, we must understand the drivers of those costs and their growth, as well as the relationship between cost and quality. Comparing Performance of Systems and Providers: AHRQ is interested in research that will allow comparison of delivery system and provider performance by health care stakeholders such as consumers, providers, payers, insurers, and policymakers. Incentives for Improving Performance: Public and private payers have provided a variety of financial and nonfinancial incentives to improve the performance of health care providers and systems. AHRQ is interested in research on the impacts of these changesโ€”both intended and otherwiseโ€”as well as how to improve incentive programs. Interventions to Improve Performance: While alignment with external incentives is very important, it is the provider or system that implements interventions to increase performance. AHRQ is interested in research on how interventions to improve quality or cost are best implemented within and spread across providers and systems.

Health
State governments